13. Transplantation And Pregnancy Flashcards
Why you have Ab against blood group B if you have blood group A f.eks
1) Carbohydrate antigens of intestinal microbiome
2) Maternal antigen exposition
3) Contact with foreign blood previously
4) Exposition by plant pollens
Autograft
Transplant from own body (e.g hair transplant)
Isograft
Transplant from monozygotic twin
Allograft
Transplant from same species
Xenograft
Transplantation from different species (e.g monkey)
Primary rejection allograft
- Necrosis
- Rejection
- Longer reaction than secondary
- Ca. 14 days
Secondary rejection allograft
- Reintroducing graft
- Necrosis
- Shorter time before rejection due to memory cells
- Ca. 5-6 days
Critical point in transplantation
1) MHC (HLA-A, HLA-B, HLA-DR)
2) Minor histocompatibility antigens
- H-Y (Y chromosome, male)
- Males preferably get grafts from other males
- HA-1 -> HA-5 (non Y chromosome)
3) Other tissue specific antigens
- ABO, Rh blood groups
- VEC (vascular endothelial cell) antigen system
- SK (Skjebred) antigen
Difference organ and bone marrow transplantation
Organ: - No cytoablation - HLA coordination important - Major complication: rejection - Success: acceptance Bone marrow - Cytoablation necessary - HLA coordination crucial - Major complication: GVHD - Success: tolerance
Types of host versus graft reactions (HVG)
1) Hyperacute rejection (minutes-hours)
- Complement activation, endoth. damage, inflammation,
- ABO, HLA, VEC incompatibility
2) Acute rejection (weeks)
- IgG binds to alloantigenic antigen
- No complement activation
- Vasculitis: IgG binds to alloantigenic endothel (Th1, CD8)
3) Chronic rejection (months)
- Fibrosis and vascular sclerosis
- CD4 T cells, macrophages
- Vessel occlusion
Hematopoietic chimera
After bone marrow transplantation
Bone marrow transplantation use
- Cancers
- Autoimmune disorders
- Other diseases
Apheresis
Harvesting stem cells from peripheral blood
GVHD (graft vs host disease) mediators
- TNF
- FasL
- Perforin-granzyme
- all from cytotoxic T cells
Types of GVHD
1) Acute
- Endothel cells damaged in skin, liver, GI system
- Delivered by graft T cells
2) Chronic
- Fibrosis + atrophy in multiple tissues
- Loss of tissue function
Biological suppression of rejection
1) Donor selection
- Family member
- Cadaver
2) Ex vivo graft manipulation
- Suppression/elimination of immunocompetent cells
- Steroid infusion helps downregulate MHC expression
Pharma-suppression of rejection
1) Cyclosporin
- Block transcription factor: NFAT (IL-2)
2) Azathioprin, cyclophosphamid
- Lymphocyte proliferation blocking
- Anti-CD3 mAb -> T cell depletion
3) Antiinflammatory agents
4) Corticosteroids
++
5 years survival heart transplant
80%
Bile system
Very immunogenic
Attacked before liver
??
Fetus
Hemiallograft in mother
50% mother, 50% father
Immunological changes during pregnancy
1) TH2 shift
2) Asymmetric Ab’s (only found in pregnancy)
3) HLA-G
4) CD8+ cells decreased -> PIBF, incr IL-10, decr NK)
5) hCG, IL-6
Abort
Acute or chronic rejection (depending on time)
Birth
Timely rejection
Primiparae hemiallograft
- First pregnancy
- 20 % production of Ab’s against paternal Ag’s
Multiparae hemiallograft
- Several pregnancies
- 40-60 % production of Ab’s against paternal Ag’s
Trophoblasts
Interphase between mother and fetus
- No MHC II
- Monomorphic MHC I-like molecules (HLA-G, HLA-E -> inhibition of CTL and NK cells)
Immunosuppression in pregnancy
Treg and γδ-cells
and TGF beta and Th2 cytokines
Endocrine effects of pregnancy
1) Maternal
- Progesterone, estrogen
2) Placental (chorion)
- hCG (human choriogonadotrop hormone)
3) Fetal
- alpha-1 fetoprotein
PIBF
Progesterone induced blocking factor
- Inhibit NK cells
- Th2 cytokine excess
- Anti-abortive effects
- Inhibits arachidoic acid metabolism
- Assymmetric antibodies upregulated
Most frequent transplantation
Transfusion (blood)
Graft vs host alloreaction
Transplantation immunocompetent tissues
Defenceless recipient
Bone marrow transplantation
Reconstruction of hematopoietic system after chemo-/radiotherapy
Host vs graft alloreaction
Transplantation of non-immunocompetent tissues
Traditional organ transplantation
Liver transplantation survival
1 year: >75%
5 years: 70 %
Pancreas transplant survival
1 year: 72 %